TriSalus Life Sciences, Inc. (TLSI)
NASDAQ·Healthcare·Medical - Devices
$4.51
+0.22%
Mkt Cap $174.96M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $12.82M | $13.21M | +3.04% | -$0.13 | -$0.12 | +7.69% | — | — |
| Q4 2025 Nov 13, 2025 | $13.20M | $11.57M | -12.38% | -$0.17 | -$0.96 | -464.71% | — | — |
| Q3 2025 Aug 12, 2025 | $11.65M | $11.21M | -3.76% | -$0.22 | -$0.27 | -22.73% | — | — |
| Q2 2025 May 15, 2025 | $9.09M | $9.17M | +0.79% | -$0.20 | -$0.33 | -65.00% | — | — |
| Q1 2025 Mar 27, 2025 | $8.12M | $8.26M | +1.79% | -$0.35 | -$0.35 | +0.00% | — | — |
| Q4 2024 Nov 14, 2024 | $7.38M | $7.35M | -0.39% | -$0.36 | -$0.40 | -11.11% | — | — |
| Q3 2024 Aug 14, 2024 | $6.88M | $7.36M | +7.06% | -$0.49 | -$0.21 | +57.14% | — | — |
| Q2 2024 May 15, 2024 | $6.17M | $6.46M | +4.69% | -$0.65 | -$0.54 | +16.92% | — | — |
| Q1 2024 Feb 27, 2024 | — | $5.72M | — | — | -$1.34 | — | — | — |
| Q4 2023 Nov 14, 2023 | — | $5.19M | — | — | -$0.13 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | $4.61M | — | — | -$0.53 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | $2.98M | — | — | -$0.31 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | $3.23M | — | — | -$0.76 | — | — | — |
| Q4 2022 Nov 10, 2022 | — | $3.92M | — | — | -$0.26 | — | — | — |
| Q3 2022 Aug 10, 2022 | — | $2.88M | — | — | $0.08 | — | — | — |
| Q2 2022 May 11, 2022 | — | $2.37M | — | — | -$0.25 | — | — | — |
| Q1 2022 Mar 2, 2022 | — | $2.57M | — | — | $0.09 | — | — | — |
| Q4 2021 Dec 13, 2021 | — | — | — | — | $0.06 | — | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | — | $0.01 | — | — | — |
| Q2 2021 Jun 28, 2021 | — | — | — | — | -$0.01 | — | — | — |